Some factors are associated with non-alcoholic steatohepatitis (NASH) and liver fibrosis, such as age, obesity, hypertension, type II diabetes, ALT, S/T > 1, and decreased platelet count [23, 24]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.